NCT02951780View on ClinicalTrials.gov

A Study of LY3185643 and rGlucagon in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

January 24, 2017

Study Completion Date

March 1, 2017

Conditions

Healthy

Interventions

DRUG

LY3185643

Administered SC

DRUG

rGlucagon

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT02951780 - A Study of LY3185643 and rGlucagon in Healthy Participants | Biotech Hunter | Biotech Hunter